ABSTRACT In some patients with rheumatoid disease gas transfer across the lungs is abnormal. We measured the membrane component of gas transfer (Dm) and pulmonary capillary volume (Vc) in 48 patients with rheumatoid arthritis and in 48 normal volunteers matched for age, sex, and smoking habits. Volunteers had normal chest radiographs and normal forced expiratory volume in one second and vital capacity. There were no significant differences between the rheumatoid and control groups for Dm. Mean Vc in rheumatoid male smokers (64-0 ml, SD 16-5) was significantly lower than in control male smokers (76-3 ml, SD 18-0 p<0 05). In rheumatoid female smokers mean Vc (43.4 ml, SD 13 3) was significantly lower than in rheumatoid female non-smokers (58.4 ml, SD 15-4 p<0 01). There was no significant difference between rheumatoid and control female non-smokers (mean Vc 58 4 ml and 60-7 ml respectively). Significant differences in Vc in terms of per cent predicted normal were found between patients receiving corticosteroids and those not receiving corticosteroids or penicillamine (p <0 02) and between patients with nodules and those without (p<0 05). Patients with persistently low transfer factor for five years had a significantly lower Vc (p<0 02). There was no consistent correlation between Dm and Vc and dynamic compliance or static recoil pressure. It appears that the abnormality of transfer factor in rheumatoid disease previously demonstrated is caused by reduction of Vc. It seems that involvement of pulmonary blood vessels occurs treatment with corticosteroids.
In their report of lung involvement in rheumatoid disease Ellman and Ball' described the pathology in two patients. In one there was interstitial pneumonitis, fibrosis between alveoli, and some endothelial proliferation with fibrinoid degeneration of blood vessels. In the other case there was interstitial pneumonitis and cuboidal epithelium was described in the alveoli. There was also intra-alveolar fibrosis but the blood vessels were normal. Subsequent reports2-5 sometimes described prominent alveolar or bronchiolar inflammatory changes and in some cases there was marked arterial involvement. Some descriptions were of fibrosis with or without arterial changes. Subsequent studies of respiratory function in rheumatoid disease6-8 showed that transfer factor (TL) was low in many patients. We have extended these observations by determining the membrane factor (Dm) and pulmonary capillary volume (Vc), the components of transfer factor, in patients with rheumatoid disease. To compare various groups of rheumatoid patients Dm and Vc were expressed as per cent predicted (PN).13 14 Mean values for various groups are given in table 2. There were no significant differences for Dm. Pulmonary capillary volume was significantly lower in patients not receiving corticosteroids (p < 0 02) and in patients with nodules (p < 0 025) but there was no significant correlation (r -0-12) with Rose Waaler titre. There was no significant relationship between Dm and Vc and the number of joints involved, nor between Dm and duration of arthritis (r = -0-24), but there was a significant relationship (p = <0-01) between Vc and duration of arthritis (r = 0 34).
In those patients who had shown persistently low TL, Vc was significantly lower (p = < 0 02) than in those whose TL had been normal at most visits. In the patients who had two out of three positive findings of cough, breathlessness, and abnormal chest radiographs at each visit compared with those who did not From Hamer'st' study of sarcoidosis and from the study of systemic sclerosis'6 it appeared that low Vc was associated with more advanced disease. In our patients Vc was significantly higher in patients with arthritis of longer duration, but 21 of the 27 patients whose arthritis had been present for more than 10 years were being treated with corticosteroids. Of eight patients not receiving corticosteroids whose Vc was less than 60% predicted, six had suffered from arthritis for less than 10 years.
Significant reduction of Vc was found in smokers rather than non-smokers and the difference between rheumatoid female smokers and non-smokers was the most significant in this study, although there was no difference between control female smokers and non-smokers. Some published results for Dm and Vc do not distinguish between smokers and non-smokers and there are more results for normal male than for normal female subjects. Frans et al'0 studied healthy men and found that Dm and Vc were both lower in smokers. It was not possible to recruit a sufficient number of rheumatoid male patients who had never smoked, but normal male non-smokers have been studied in our laboratory. Pulmonary capillary volume was not significantly different from healthy male smokers. There is a suggestion from our results that the combination of rheumatoid disease and smoking reduces pulmonary capillary volume.
The patients in our study had been seen on a number of occasions and in 17 TL had been persistently low. This was not explained by anaemia, which is common in rheumatoid disease. In these patients with persistently low TL Vc was significantly lower than in the other rheumatoid patients. In six of these 17 patients Kco was normal. It might be expected in these patients that the low transfer factor would be caused by low Dm associated with reduced alveolar volume. Membrane factor was low in three cases, in one of whom alveolar volume was low.
From equation 3, since Vc is the capillary volume and 0 the rate of uptake of oxygen by the red cell, it follows that the variable Dm must include the other factors influencing TL-that is, both ventilation of the alveoli and the structure and area of the alveolar wall and capillary membrane. Uneven and reduced alveolar ventilation could be caused by airways obstruction. Although this (FEV, 2 SD below mean predicted normal) was fairly common in our patients and is associated with smoking, we found no evidence that it was associated with abnormal Dm or Vc. Georges et al'6 found a highly significant correlation of effective compliance with Vc, but not with Dm. The sex and smoking habits of their patients were not given. It is probable that the majority of patients with systemic sclerosis were female, possibly non-smokers. Macklem and Becklake23 found that in emphysema both recoil pressure and TL were reduced, in asthma recoil pressure and TL were normal, but in pulmonary fibrosis there was no correlation between the two measurements. In rheumatoid disease a greatly increased recoil pressure is attributable to fibrotic changes in the lungs. On the other hand, patients with joint involvement of the thoracic cage or muscles might produce smaller pressures and therefore lower Dm as a result of failure to achieve full ventilation of the alveoli. The mixture of these different problems would make it impossible to detect individual effects when studying the group as a whole.
Although in our patients there is a suggestion that in women there may be some relationship of Dm measurements to the mechanical properties of the lung, the notable abnormality is the reduction in Vc. This appears to be related to both smoking and rheumatoid disease and the change seems to be suppressed by treatment with corticosteroids. 
